Hema Now: Episode 28: Charting a New Era in Myeloma Care

In this episode of Hema Now, Pieter Sonneveld, Chair of the European Myeloma Network (EMN) and a leading voice in haematology, discusses how research and collaborative trials, like PERSEUS and CEPHEUS, are redefining standards of care in multiple myeloma. From the importance of early diagnosis to the evolving role of minimal residual disease testing, this conversation offers a forward-looking perspective on what's next for patients and clinicians alike.  Timestamps    00:00 – Introduction  01:36 – Initial interest in multiple myeloma  03:24 – Treatment landscape  05:25 – Minimal residual disease  08:20 – European Myeloma Network (EMN)  11:04 – Overview of the PERSEUS trial   14:37 – Overview of the CEPHEUS trial  17:45 – The future of myeloma care  20:38 – Pieter's three wishes for healthcare   

There are no comments yet.

Please log in to write the first comment.